HEADER PROTEIN BINDING 30-NOV-07 2JXX TITLE NMR SOLUTION STRUCTURE OF UBIQUITIN-LIKE DOMAIN OF NFATC2IP. NORTHEAST TITLE 2 STRUCTURAL GENOMICS CONSORTIUM TARGET HR5627 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NFATC2-INTERACTING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UBIQUITIN-LIKE DOMAIN: RESIDUES 342-419; COMPND 5 SYNONYM: NUCLEAR FACTOR OF ACTIVATED T-CELLS, CYTOPLASMIC 2- COMPND 6 INTERACTING PROTEIN, 45 KDA NFAT-INTERACTING PROTEIN, 45 KDA NF-AT- COMPND 7 INTERACTING PROTEIN; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NFATC2IP, NIP45; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28-MHL KEYWDS NUCLEAR FACTOR OF ACTIVATED T-CELLS, CYTOPLASMIC 2-INTERACTING KEYWDS 2 PROTEIN, UBIQUITIN LIKE HOMOLOGUE, NFAT COMPLEX, ALTERNATIVE KEYWDS 3 SPLICING, COILED COIL, METHYLATION, NUCLEUS, PHOSPHOPROTEIN, KEYWDS 4 POLYMORPHISM, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE KEYWDS 5 INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, KEYWDS 6 STRUCTURAL GENOMICS CONSORTIUM, SGC, PROTEIN BINDING EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR R.S.DOHERTY,S.DHE-PAGANON,C.FARES,A.LEMAK,C.BUTLER,S.SRISAILAM, AUTHOR 2 M.KARRA,A.YEE,A.M.EDWARDS,J.WEIGELT,C.H.ARROWSMITH,NORTHEAST AUTHOR 3 STRUCTURAL GENOMICS CONSORTIUM (NESG),STRUCTURAL GENOMICS CONSORTIUM AUTHOR 4 (SGC) REVDAT 3 19-FEB-20 2JXX 1 REMARK SEQADV REVDAT 2 24-FEB-09 2JXX 1 VERSN REVDAT 1 11-DEC-07 2JXX 0 JRNL AUTH R.S.DOHERTY,S.DHE-PAGANON,C.FARES,A.LEMAK,C.BUTLER, JRNL AUTH 2 S.SRISAILAM,M.KARRA,A.YEE,J.WEIGELT,A.M.EDWARDS, JRNL AUTH 3 C.H.ARROWSMITH JRNL TITL SOLUTION STRUCTURE OF UBIQUITIN-LIKE DOMAIN OF NFATC2IP. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1, CNS 1.1, PSVS, WHAT IF REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), BRUNGER, ADAMS, CLORE, GROS, NILGES AND REMARK 3 READ (CNS), BHATTACHARYA AND MONTELIONE (PSVS), REMARK 3 VRIEND (WHAT IF) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESTRAINED MOLECULAR DYNAMICS IN REMARK 3 EXPLICIT WATER BATH. REMARK 4 REMARK 4 2JXX COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-DEC-07. REMARK 100 THE DEPOSITION ID IS D_1000100428. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 8 REMARK 210 IONIC STRENGTH : 500 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 500 MM NACL, 50 MM TRIS-HCL, 1 REMARK 210 MM BENZAMIDINE, 0.01 % NAN3, 0.9 REMARK 210 MM [U-15N] NFATC2IP, 0.01 MM REMARK 210 ZNSO4, 90% H2O/10% D2O; 500 MM REMARK 210 NACL, 50 MM TRIS-HCL, 1 MM REMARK 210 BENZAMIDINE, 0.01 % NAN3, 0.9 MM REMARK 210 [U-13C; U-15N] NFATC2IP, 0.01 MM REMARK 210 ZNSO4, 100% D2O; 500 MM NACL, 50 REMARK 210 MM TRIS-HCL, 1 MM BENZAMIDINE, REMARK 210 0.01 % NAN3, 0.9 MM [U-13C; U- REMARK 210 15N] NFATC2IP, 0.01 MM ZNSO4, 90% REMARK 210 H2O/10% D2O; 500 MM NACL, 50 MM REMARK 210 TRIS-HCL, 1 MM BENZAMIDINE, 0.01 REMARK 210 % NAN3, 0.9 MM [U-13C; U-15N] REMARK 210 NFATC2IP, 0.01 MM ZNSO4, 12 MG/ REMARK 210 ML PF1 CO-SOLVENT PROTEASE FREE REMARK 210 PHAGE, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C REMARK 210 CONSTANT TIME HSQC; 3D HNCO; 3D REMARK 210 HNCA; 3D CBCA(CO)NH; 3D HBHA(CO) REMARK 210 NH; 3D 1H-13C NOESY; 3D 1H-13C REMARK 210 AROMATIC NOESY; 3D HCCH-TOCSY; REMARK 210 2D 1H-15N IPAP HSQC; 3D 1H-15N REMARK 210 NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, TALOS, SPARKY, TOPSPIN REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 HIS A 5 REMARK 465 HIS A 6 REMARK 465 HIS A 7 REMARK 465 HIS A 8 REMARK 465 HIS A 9 REMARK 465 HIS A 10 REMARK 465 SER A 11 REMARK 465 SER A 12 REMARK 465 GLY A 13 REMARK 465 LEU A 14 REMARK 465 VAL A 15 REMARK 465 PRO A 16 REMARK 465 ARG A 17 REMARK 465 GLY A 18 REMARK 465 SER A 19 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 21 -45.00 -141.17 REMARK 500 1 THR A 22 79.76 -108.12 REMARK 500 1 SER A 63 99.28 -56.19 REMARK 500 2 GLU A 21 -45.99 -140.62 REMARK 500 2 THR A 22 78.94 -110.95 REMARK 500 2 SER A 23 67.35 -103.51 REMARK 500 2 LYS A 33 20.49 -70.65 REMARK 500 2 LEU A 62 33.52 -91.12 REMARK 500 2 SER A 89 13.97 -62.61 REMARK 500 3 SER A 23 100.57 -39.78 REMARK 500 3 SER A 63 95.55 -61.59 REMARK 500 3 SER A 89 15.04 -63.38 REMARK 500 4 SER A 89 108.65 -59.92 REMARK 500 5 GLU A 21 -17.62 -141.09 REMARK 500 5 LYS A 33 -39.94 -37.50 REMARK 500 5 LEU A 62 45.99 -87.04 REMARK 500 6 GLN A 37 84.36 -69.48 REMARK 500 6 SER A 44 120.49 -32.92 REMARK 500 7 SER A 23 74.14 -40.26 REMARK 500 7 SER A 63 97.75 -62.79 REMARK 500 8 SER A 23 81.47 -46.36 REMARK 500 8 LYS A 33 -37.15 -39.66 REMARK 500 8 GLN A 37 94.94 -67.03 REMARK 500 8 ASP A 91 175.85 -54.64 REMARK 500 9 GLU A 21 -40.97 -133.57 REMARK 500 9 SER A 23 70.95 -67.72 REMARK 500 9 LEU A 62 47.82 -90.53 REMARK 500 9 ARG A 65 90.44 -68.34 REMARK 500 10 LYS A 33 -39.89 -36.03 REMARK 500 10 ASP A 91 -160.89 -102.87 REMARK 500 12 GLU A 21 -47.50 -140.61 REMARK 500 12 THR A 22 79.27 -114.24 REMARK 500 12 SER A 23 66.28 -100.95 REMARK 500 12 SER A 63 102.35 -59.99 REMARK 500 13 SER A 23 70.25 -101.85 REMARK 500 13 GLN A 37 87.33 -68.71 REMARK 500 13 SER A 63 85.10 -68.07 REMARK 500 14 THR A 22 79.58 -101.05 REMARK 500 14 SER A 63 91.35 -62.70 REMARK 500 15 ASP A 91 172.72 -58.08 REMARK 500 16 GLU A 21 -49.25 -141.16 REMARK 500 16 SER A 23 66.18 -100.96 REMARK 500 16 GLN A 37 88.85 -69.60 REMARK 500 16 LEU A 62 70.90 -68.45 REMARK 500 17 LEU A 62 42.01 -94.30 REMARK 500 17 ASP A 91 170.81 -52.70 REMARK 500 18 LYS A 33 -37.35 -39.52 REMARK 500 18 ASP A 91 -159.46 -110.07 REMARK 500 19 SER A 23 86.86 -66.41 REMARK 500 19 LYS A 33 -16.45 -48.43 REMARK 500 REMARK 500 THIS ENTRY HAS 54 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 21 THR A 22 5 -135.12 REMARK 500 THR A 22 SER A 23 5 -134.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HR5627 RELATED DB: TARGETDB REMARK 900 RELATED ID: 15576 RELATED DB: BMRB DBREF 2JXX A 20 97 UNP Q8NCF5 NF2IP_HUMAN 342 419 SEQADV 2JXX MET A 1 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX GLY A 2 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX SER A 3 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX SER A 4 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX HIS A 5 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX HIS A 6 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX HIS A 7 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX HIS A 8 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX HIS A 9 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX HIS A 10 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX SER A 11 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX SER A 12 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX GLY A 13 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX LEU A 14 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX VAL A 15 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX PRO A 16 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX ARG A 17 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX GLY A 18 UNP Q8NCF5 EXPRESSION TAG SEQADV 2JXX SER A 19 UNP Q8NCF5 EXPRESSION TAG SEQRES 1 A 97 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 97 LEU VAL PRO ARG GLY SER THR GLU THR SER GLN GLN LEU SEQRES 3 A 97 GLN LEU ARG VAL GLN GLY LYS GLU LYS HIS GLN THR LEU SEQRES 4 A 97 GLU VAL SER LEU SER ARG ASP SER PRO LEU LYS THR LEU SEQRES 5 A 97 MET SER HIS TYR GLU GLU ALA MET GLY LEU SER GLY ARG SEQRES 6 A 97 LYS LEU SER PHE PHE PHE ASP GLY THR LYS LEU SER GLY SEQRES 7 A 97 ARG GLU LEU PRO ALA ASP LEU GLY MET GLU SER GLY ASP SEQRES 8 A 97 LEU ILE GLU VAL TRP GLY HELIX 1 1 PRO A 48 MET A 60 1 13 HELIX 2 2 LEU A 81 GLY A 86 1 6 SHEET 1 A 5 THR A 38 SER A 44 0 SHEET 2 A 5 GLN A 25 GLY A 32 -1 N LEU A 26 O LEU A 43 SHEET 3 A 5 ASP A 91 TRP A 96 1 O ILE A 93 N ARG A 29 SHEET 4 A 5 SER A 68 PHE A 71 -1 N PHE A 70 O GLU A 94 SHEET 5 A 5 THR A 74 LYS A 75 -1 O THR A 74 N PHE A 71 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1